"Comparison of Shockwave Application on the Sole of the Foot Vs. the Back of the Leg in the Treatment of Plantar Fasciitis: a Clinical Trial."
Launched by UNIVERSITY OF ALCALA · Sep 5, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called plantar fasciitis, which causes pain in the bottom of the foot and is a common issue for many people. The researchers want to find out how effective shock wave therapy is for treating this pain when applied either directly to the foot or along the back of the leg. They will compare the results to see which method helps reduce pain, improves foot and ankle function, and enhances overall quality of life for those suffering from this condition.
To participate in the trial, individuals must be between 18 and 65 years old, have been diagnosed with plantar fasciitis, and have been experiencing pain for at least a month. However, pregnant women, people with certain medical conditions like a pacemaker or rheumatoid arthritis, and those with blood clotting issues cannot join. Participants will receive one of the two types of shock wave therapy and will have their progress checked at several points over three months to see how well the treatment is working. This study aims to provide valuable information that could help improve treatment options for plantar fasciitis.
Gender
ALL
Eligibility criteria
- • Inclusion criteria: having been diagnosed with plantar fasciitis, experiencing pain related to the condition for at least 1 month, and being between 18 and 65 years of age.
- • Exclusion criteria: being pregnant, having a pacemaker, presenting with rheumatoid arthritis, or having coagulation disorders.
About University Of Alcala
The University of Alcalá, a prestigious institution located in Spain, is committed to advancing medical research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking studies in various fields of healthcare. By fostering partnerships with industry leaders and healthcare professionals, the University of Alcalá aims to enhance patient outcomes and contribute to the global body of medical knowledge. Its dedication to rigorous research methodologies ensures the integrity and reliability of clinical trials, promoting a culture of excellence in scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcala De Henares, Madrid, Spain
Patients applied
Trial Officials
Paula Fernandez-Martin
Principal Investigator
University of Alcala
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported